US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AgomAb Therapeutics

14.65

-1.3500-8.44%

Post-market: 15.270.6200+4.23%19:59 EST

Volume:2.36M

Turnover:33.65M

Market Cap:713.99M

PE:- -

High:15.49

Open:14.70

Low:12.66

Close:16.00

52wk High:15.49

52wk Low:12.66

Shares:48.74M

Float Shares:12.50M

Volume Ratio:- -

T/O Rate:18.90%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:-3.96

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

AgomAb Therapeutics

Exchange:

NASDAQ

Establishment Date:

2017

Employees:

62

Office Location:

Posthoflei 1/6,Antwerp,Antwerp,Belgium

Website:

http://www.agomab.com

Zip Code:

2600

Phone:

Fax:

- -

Introduction:

- -

Directors

Name

Position

David Epstein

Chairman of the Board

Tim Knotnerus

Chief Executive Officer and Executive Director

Angelika Jahreis

Non-Executive Director

Colin Bond

Non-Executive Director

Felice Verduyn van Weegen

Non-Executive Director

Ohad Hammer

Non-Executive Director

Shareholders

Name

Position

Tim Knotnerus

Chief Executive Officer and Executive Director

Pierre Kemula

Chief Financial Officer

Andrea Saez

Chief Development Officer

Ellen Lefever

General Counsel

Paul van der Horst

Chief Business Officer

Philippe Wiesel

Chief Medical Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AGMB/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AGMB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGMB\",,,,,undefined,":{"symbol":"AGMB","market":"US","secType":"STK","nameCN":"AgomAb Therapeutics","latestPrice":14.65,"timestamp":1770411600000,"preClose":16,"halted":0,"volume":2362247,"hourTrading":{"tag":"盘后","latestPrice":15.27,"preClose":14.65,"latestTime":"19:59 EST","volume":48416,"amount":700627.0362,"timestamp":1770425974974,"change":0.62,"changeRate":0.042321,"amplitude":0.126962},"delay":0,"changeRate":-0.08437499999999998,"floatShares":12500000,"shares":48736779,"eps":0,"marketStatus":"Closed","change":-1.35,"latestTime":"02-06 16:00:00 EST","open":14.7,"high":15.49,"low":12.66,"amount":33646693.491464004,"amplitude":0.176875,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":5,"adr":0,"listingDate":1770354000000,"exchange":"NASDAQ","adjPreClose":16,"postHourTrading":{"tag":"盘后","latestPrice":15.27,"preClose":14.65,"latestTime":"19:59 EST","volume":48416,"amount":700627.0362,"timestamp":1770425974974,"change":0.62,"changeRate":0.042321,"amplitude":0.126962},"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGMB\",,,,,undefined,":{"symbol":"AGMB","floatShares":12500000,"roa":"--","roe":"--","lyrEps":0,"shares":48736779,"dividePrice":0,"high":15.49,"amplitude":0.176875,"preClose":16,"low":12.66,"week52Low":12.66,"pbRate":"-3.96","week52High":15.49,"institutionHeld":0,"latestPrice":14.65,"eps":0,"divideRate":0,"volume":2362247,"delay":0,"ttmEps":0,"open":14.7,"prevYearClose":16,"fiveDayClose":16,"twentyDayClose":16,"sixtyDayClose":16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AGMB\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AGMB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AGMB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":563168576,"yearFounded":2017,"employeeNum":62,"address":"Posthoflei 1/6,Antwerp,Antwerp,Belgium","zipCode":"2600","officePhone":"32 3 318 91 70"},"stockCompanyDetail":{"websiteUrl":"http://www.agomab.com","stockEarnings":[{"period":"1week","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0237},{"period":"1month","weight":-0.0205},{"period":"3month","weight":0.0099},{"period":"6month","weight":0.0635},{"period":"1year","weight":0.1215},{"period":"ytd","weight":-0.0063}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"AgomAb Therapeutics","nameEN":"AgomAb Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"AGMB\",market:\"US\",,,undefined,":{"directors":[{"name":"David Epstein","position":"Chairman of the Board"},{"name":"Tim Knotnerus","position":"Chief Executive Officer and Executive Director"},{"name":"Angelika Jahreis","position":"Non-Executive Director"},{"name":"Colin Bond","position":"Non-Executive Director"},{"name":"Felice Verduyn van Weegen","position":"Non-Executive Director"},{"name":"Ohad Hammer","position":"Non-Executive Director"}],"executives":[{"name":"Tim Knotnerus","position":"Chief Executive Officer and Executive Director"},{"name":"Pierre Kemula","position":"Chief Financial Officer"},{"name":"Andrea Saez","position":"Chief Development Officer"},{"name":"Ellen Lefever","position":"General Counsel"},{"name":"Paul van der Horst","position":"Chief Business Officer"},{"name":"Philippe Wiesel","position":"Chief Medical Officer"}]}}}